5-dimethylthiazolidine 3- (2'- benzyl- 3'- mercaptopropanoyl)- 4- carboxy- 5
tight-binding inhibitor of the metallo-beta-lactamase from Bacteroides fragilis; structure in first source
Also Known As:
3-(2'-benzyl-3'-mercaptopropanoyl)-4-carboxy-5, 5-dimethylthiazolidine; 3-(2'-(S)-benzyl-3'-mercaptopropanoyl)-4-(S)-carboxy-5, 5-dimethylthiazolidine; SB 225666; SB225666
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Communicable Diseases (Infectious Diseases)
05/01/2000
- " This year's lectures covered the identification and development of novel therapeutics for the treatment of asthma (GW-215864X, GW-250495X, CT-5219, CT-5627), immunosuppressants (AR-C70651XX, AR-C95650XX, AR-C110228XX, AR-C124908XX, AR-C123221XX, AR-C125190XX), infectious diseases (SB-225666, SB-227943, SB-252619; Ro-32-4931, Ro-32-6896, Ro-32-6888) and CNS disorders (UK-203368, UK-240255, UK-142455, UK-155261; L-811619, L-830844, L-838751, L-838912, L-838913), and highlighted some of the pitfalls that can bedevil drug development programs."
|
2. | Asthma (Bronchial Asthma)
05/01/2000
- " This year's lectures covered the identification and development of novel therapeutics for the treatment of asthma (GW-215864X, GW-250495X, CT-5219, CT-5627), immunosuppressants (AR-C70651XX, AR-C95650XX, AR-C110228XX, AR-C124908XX, AR-C123221XX, AR-C125190XX), infectious diseases (SB-225666, SB-227943, SB-252619; Ro-32-4931, Ro-32-6896, Ro-32-6888) and CNS disorders (UK-203368, UK-240255, UK-142455, UK-155261; L-811619, L-830844, L-838751, L-838912, L-838913), and highlighted some of the pitfalls that can bedevil drug development programs."
|
|
Related Drugs and Biologics
Related Therapies and Procedures